tiprankstipranks
Valneva reports Phase 2 results in children for its chikungunya vaccine
PremiumThe FlyValneva reports Phase 2 results in children for its chikungunya vaccine
1M ago
Valneva submits label extension application for chikungunya vaccine to FDA
Premium
The Fly
Valneva submits label extension application for chikungunya vaccine to FDA
3M ago
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
Premium
The Fly
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
4M ago
0OB3 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings0OB3 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Pfizer, Valneva announce vaccination series completion in VALOR trial
Premium
The Fly
Pfizer, Valneva announce vaccination series completion in VALOR trial
7M ago
Valneva announces positive CHMP opinion for chikungunya vaccine
Premium
The Fly
Valneva announces positive CHMP opinion for chikungunya vaccine
9M ago
Valneva announces FDA approval of Ixciq
PremiumThe FlyValneva announces FDA approval of Ixciq
1y ago
Valneva announces FDA approval of Ixciq
Premium
The Fly
Valneva announces FDA approval of Ixciq
1y ago
Valneva price target raised to $26 from $22 at H.C. Wainwright
Premium
The Fly
Valneva price target raised to $26 from $22 at H.C. Wainwright
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100